Global 2018 Drug Development Biometric Services Procurement Market Report - Increase in Data Security by Regulators is Driving the Market -

One of the best procurement practices for the buyers is to establish data security and integrity protocols.

According to the report, one of the key growth contributors for the global drug development biometric services market is an increase in data security by regulators. Drug researchers and developers are subjected to regulations that aim to establish protocols for the protection of the data, which is collected during a drug development process. Further, the report states that major procurement challenge experienced by the buyers is the need for clinical trial process re-engineering.

The report provides actionable insights to improve source-to-contract cycle performance in the Global Drug Development Biometric Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.

The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

Key Suppliers

  • Covance
  • AbbVie
  • PPD

Key Topics Covered

Part 1: Category at a Glance

Part 2: Scope of the Report

Part 3: Market Insights

Part 4: Supply Market Insights

Part 5: Pricing Insights

Part 6: Procurement Insights

Part 7: Top Five Suppliers

For more information about this report visit

Back to news